Streetbeat News

Regulatory

ASML

The Dutch government has expanded export restrictions on advanced semiconductor manufacturing equipment, impacting ASML Holding N.V. (NASDAQ:ASML). These restrictions are seen as a national security measure and align with U.S. efforts to limit exports to China. ASML states that the changes are technical and won't affect its financial outlook for 2024.

Portfolio Pulse from Benzinga Neuro

September 06, 2024 | 12:12 pm

NVDA

Nvidia's AI chips, despite US export restrictions, are available for rent in China at lower rates than in the US. This suggests a significant supply of Nvidia chips in China, potentially bypassing US restrictions.

Portfolio Pulse from Benzinga Neuro

September 06, 2024 | 12:11 pm

BA

Boeing's Starliner spacecraft is set to undock from the ISS for a crewless landing in New Mexico after NASA decided to return astronauts via SpaceX due to technical concerns. The decision followed a tense discussion over thruster degradation issues.

Portfolio Pulse from Anan Ashraf

September 06, 2024 | 11:55 am

GOOG

GOOGL

The UK's Competition and Markets Authority (CMA) has raised objections to Google's ad tech practices, alleging that Google is using its dominance in online display advertising to favor its own services, impacting competition in the UK.

Portfolio Pulse from Benzinga Neuro

September 06, 2024 | 11:40 am

CDAQ

Compass Digital Acquisition (CDAQ) has announced a business combination with EEW Renewables, valuing the enterprise at $386 million. The deal is expected to close in Q1 2025, with EEW shareholders owning 79% of the new entity. The combined company plans to list on Nasdaq.

Portfolio Pulse from Nabaparna Bhattacharya

September 06, 2024 | 11:36 am

TVTX

Travere Therapeutics' shares rose following FDA's full approval of FILSPARI for treating primary IgAN. HC Wainwright & Co also maintained a Buy rating and increased the price target from $20 to $23.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 11:32 am

CDAQ

Trading has been halted at 7:25:00 a.m. ET due to pending news. This halt affects the CDAQ, which may indicate significant news is forthcoming.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 11:25 am

NDAQ

Nasdaq reaffirms its medium-term growth outlook for all divisions, including AxiomSL and Calypso, and maintains its 2024 expectations. A $32 million one-time, non-cash GAAP revenue reduction will be recorded in Q3 2024 due to an accounting change affecting AxiomSL subscription revenue.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 11:11 am

AXGN

Axogen has completed the submission of a Biologics License Application to the FDA for its Avance Nerve Graft, a significant step in the regulatory process for the product.

Portfolio Pulse from Nabaparna Bhattacharya

September 06, 2024 | 11:10 am

NDAQ

Nasdaq has announced a change in the accounting treatment of revenues related to AxiomSL on-premises subscription contracts. This adjustment may impact how revenues are reported in future financial statements.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 11:09 am